🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today, senators sent letters to Eli Lilly and Pfizer demanding answers about their telehealth partnerships, probing whether they might violate the federal anti-kickback statute. An exclusive for STAT: statnews.com/2024/10/22/sen…

The National Academies weighed in on how race and ethnicity is used in biomedical research — finding inappropriate and harmful use that continues to wrongly suggest race is biological. For STAT with Usha Lee McFarling, their recs for how to do it right: statnews.com/2024/10/30/nat…

Trump has won the presidency. Here's what that means for health care statnews.com/2024/11/06/pre…

Want to support science journalism — and get some of the best coverage you'll find on health and medicine? statnews.com/stat-plus/ Follow the link on the page for discounted rates for students and nonprofits interested in a STAT sub.

we've made big investments in our DC coverage ahead of this moment, and so I know we have a great team of reporters in place to bring readers the news they need on health & science

If confirmed, RFK Jr. will take the reins at a $1.7 trillion agency that oversees vaccines, medicines, scientific research, public health infrastructure, and the health care plans of millions of Americans. statnews.com/2024/11/14/tru…

Here's what you need to know about the FDA's meeting on generative AI regulation tomorrow, from Katie Palmer and Casey Ross statnews.com/2024/11/19/fda…

For STAT, science & health experts shared with me why they're moving to Bluesky, and what they think the platform shift could mean for science communication and public health messaging: statnews.com/2024/11/21/blu…

What could Trump mean for the business of health? Insiders say the CDC is the most vulnerable target, while FDA changes would be slower. New column from Matthew Herper. trib.al/pN5oVLK

NEWS: Trump picks Johns Hopkins surgeon Makary to run FDA statnews.com/2024/11/22/tru… via STAT

Trump’s pick to run FDA is a top exec of a telehealth company that provides compounded GLP-1s. Comes as FDA is caught in a heated fight between pharma companies making the branded drugs and compounders via John Wilkerson, Rachel Cohrs Zhang, Katie Palmer statnews.com/2024/11/24/mak…

New STAT from me: HHS' Office of Civil Rights hasn't audited HIPAA compliance since 2017. These audits, required by the HITECH Act, are supposed to assess things like cybersecurity readiness, but OCR only looked at 8 of 180 HIPAA factors 😳 More: statnews.com/2024/11/26/fed…

This is astonishing especially because self-reported large health data breaches hit an all-time high last year, impacting more than 165 million individuals — half the U.S. population. Imagine how much higher the number would be if OCR did regular audits.

DeepSeek a relatively unknown AI firm based in China, shocked the industry last week, claiming its technology could rival US companies. What might be the impact fort AI-driven drug development? statnews.com/2025/02/03/chi… via STAT

In just a 6 days, STAT will be holding our annual NYC summit, STAT Breakthrough East. It will represent a moment to look at what's going on in pharmaceutical R&D -- our normal bread and butter -- and also to look at how disruptions at the NIH, FDA and CDC are changing the

The explosion of compounded GLP-1s is ending, and many patients are left with no good options Telehealth cos and compounders are pursuing workarounds that may be riskier. At the same time, patients still can't afford the branded drugs. w/ Katie Palmer statnews.com/2025/04/29/com…

Are you a physician or health care provider using AI tools like OpenEvidence? I want to hear about your experience! I'm a health tech journalist STAT reporting on clinical AI, and you can find me on Signal at palmer.01 (email in bio)